Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Why DexCom Stock Flopped on Friday
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth. 
Via The Motley Fool
Analyst Expectations For DexCom's Future
Via Benzinga
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Via Benzinga
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses. 
Via Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
The major indexes were mixed for the week. 
Via Investor's Business Daily
Where Will DexCom Be in 5 Years?
Recent developments might have scared away some investors, but patience could pay off. 
Via The Motley Fool
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
Via Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Looking Into DexCom's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today
Via Benzinga
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
What the Options Market Tells Us About DexCom
Via Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
DexCom reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
The company continues to expect 11% to 13% organic sales growth this year. 
Via Investor's Business Daily
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
Cheniere Energy (LNG) is a buy, while GE Vernova (GEV) may sell off on good news. HubSpot (HUBS) is risky, NuScale Power (SMR) is losing money, and AST SpaceMobile (ASTS) is overvalued. 
Via Benzinga
Is DexCom a Millionaire Maker?
It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible. 
Via The Motley Fool
Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
A discounted stock can present an opportunity when there's a quality business behind it. 
Via The Motley Fool
Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
Down More Than 50% From Its High, Is DexCom Stock a Buy?
Is DexCom's business in trouble, or could this be a great buying opportunity for investors? 
Via The Motley Fool
2 Beaten-Down Growth Stocks You Might Regret Not Buying
Their headwinds won't last forever. 
Via The Motley Fool
Is DexCom a Millionaire Maker?
The company's game-changing technology could improve the lives of hundreds of millions of patients. 
Via The Motley Fool
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Down More Than 50%, Is DexCom Stock a Bargain Now?
Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market. 
Via The Motley Fool
2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
Sometimes, a discounted stock can present a valuable opportunity. 
Via The Motley Fool
DexCom Is Great. Here's Why You Shouldn't Buy It.
Two key uncertainties make the prospect of buying it today riskier than is desirable. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.